COPT Defense Properties $CDP Shares Acquired by Cramer Rosenthal Mcglynn LLC

Key Points

• Cramer Rosenthal McGlynn LLC increased its stake in COPT Defense Properties by 35.1% in Q3, acquiring 46,775 shares to hold 180,088 shares worth about $5.23 million (≈0.16% of the company).
• Several analysts have raised ratings and price targets, leaving the stock with a consensus “Moderate Buy” and a consensus target price of $33.88 after multiple upgrades.
• COPT beat quarterly EPS expectations ($0.70 vs. $0.68), set FY2026 guidance of 2.71–2.79 EPS, and raised its quarterly dividend to $0.32 (4.0% yield) with a payout ratio of 90.37%.

Cramer Rosenthal Mcglynn LLC grew its stake in shares of COPT Defense Properties (NYSE:CDP - Free Report) by 35.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 180,088 shares of the company's stock after acquiring an additional 46,775 shares during the period. Cramer Rosenthal Mcglynn LLC owned about 0.16% of COPT Defense Properties worth $5,233,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Financial Consulate Inc. acquired a new position in COPT Defense Properties during the third quarter worth $39,000. EverSource Wealth Advisors LLC increased its position in shares of COPT Defense Properties by 1,176.5% in the second quarter. EverSource Wealth Advisors LLC now owns 1,685 shares of the company's stock valued at $46,000 after buying an additional 1,553 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of COPT Defense Properties by 31.2% during the 3rd quarter. GAMMA Investing LLC now owns 1,973 shares of the company's stock worth $57,000 after buying an additional 469 shares during the last quarter. Osaic Holdings Inc. boosted its position in shares of COPT Defense Properties by 59.6% in the 2nd quarter. Osaic Holdings Inc. now owns 3,193 shares of the company's stock worth $88,000 after buying an additional 1,192 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its stake in COPT Defense Properties by 14.1% in the 2nd quarter. PNC Financial Services Group Inc. now owns 4,988 shares of the company's stock valued at $138,000 after acquiring an additional 617 shares during the last quarter.

Analyst Upgrades and Downgrades

CDP has been the topic of several recent research reports. Cantor Fitzgerald upped their price target on shares of COPT Defense Properties from $33.00 to $37.00 and gave the company an "overweight" rating in a report on Monday, February 9th. Evercore reiterated an "outperform" rating on shares of COPT Defense Properties in a report on Friday, February 6th. Wells Fargo & Company raised their price target on COPT Defense Properties from $30.00 to $33.00 and gave the stock an "overweight" rating in a research report on Tuesday, November 25th. Citigroup upped their price objective on COPT Defense Properties from $29.00 to $34.00 and gave the company a "neutral" rating in a research report on Tuesday, February 10th. Finally, Jefferies Financial Group increased their price objective on COPT Defense Properties from $33.00 to $34.00 and gave the company a "buy" rating in a research note on Tuesday, January 27th. Five analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $33.88.

COPT Defense Properties Price Performance

Shares of NYSE:CDP opened at $32.40 on Friday. The business has a fifty day simple moving average of $30.63 and a 200-day simple moving average of $29.64. COPT Defense Properties has a 52 week low of $23.92 and a 52 week high of $32.82. The company has a market cap of $3.67 billion, a P/E ratio of 24.00 and a beta of 0.86. The company has a quick ratio of 3.95, a current ratio of 3.95 and a debt-to-equity ratio of 1.77.

COPT Defense Properties (NYSE:CDP - Get Free Report) last posted its quarterly earnings results on Thursday, February 5th. The company reported $0.70 EPS for the quarter, beating the consensus estimate of $0.68 by $0.02. The company had revenue of $197.36 million during the quarter, compared to analysts' expectations of $188.79 million. COPT Defense Properties had a return on equity of 9.82% and a net margin of 19.94%.The firm's revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.65 EPS. COPT Defense Properties has set its FY 2026 guidance at 2.710-2.790 EPS and its Q1 2026 guidance at 0.670-0.690 EPS. Equities research analysts forecast that COPT Defense Properties will post 2.67 EPS for the current year.

COPT Defense Properties Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.32 per share. This is an increase from COPT Defense Properties's previous quarterly dividend of $0.31. This represents a $1.28 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date of this dividend is Tuesday, March 31st. COPT Defense Properties's payout ratio is 90.37%.

Insider Buying and Selling at COPT Defense Properties

In other news, Director Philip L. Hawkins sold 5,536 shares of the business's stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $32.71, for a total transaction of $181,082.56. Following the completion of the sale, the director directly owned 15,188 shares of the company's stock, valued at $496,799.48. The trade was a 26.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.42% of the stock is currently owned by company insiders.

About COPT Defense Properties

COPT Defense Properties NYSE: CDP is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company's portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.